Table 4

Sensitivity analysis (costs of scenarios 3 to 5 estimated on the 189 episodes of illness assuming that 50% of malaria-negative patients were treated with anti-malarials (October 2008 and January 2009).

RDT Positive

RDT Negative

EI treated

Cost of RDT & ACT

Total cost (study sample)

Total cost per 1000 EI*

Scenario 3 modified: Treatment of all EI* RDT positive & 50% of EI RDT negative

(number of RDT = 189, number of ACT course = 102)

RDT cost

115.29

ACT cost

95.89

211.18

1117.35

1-6 y

6

92

52

24.4

7-13 y

4

27

17.5

15.2

> 13 y

5

55

32.5

56.2

Scenario 4 modified: Treatment of febrile EI* RDT positive & 50% of febrile EI RDT negative

(number of RDT = 94, number of ACT course = 51)

RDT cost

57.95

ACT cost

36.05

94.00

497.35

1-6 y

6

64

38

17.86

7-13 y

1

8

5

4.35

> 13 y

1

14

8

13.84

Scenario 5 modified: Treatment of all children ≤ 6 and of all EI* RDT positive & 50% of EI RDT negative for patients > 6

(number of RDT = 91, number of ACT course = 88)

RDT cost

55.51

ACT cost

117.51

173.02

915.45

1-6 y

98

46.06

7-13 y

4

27

17.5

15.22

> 13 y

5

55

32.5

56.23

Ly et al. Malaria Journal 2010 9:153   doi:10.1186/1475-2875-9-153